Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.
This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.
Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.
The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.
Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.
Several articles recently addressed a study which found that providing buprenorphine after an overdose significantly increased the likelihood of individuals accessing opioid use disorder (OUD) treatment.
The current protocol for paramedics and emergency departments in treating opioid overdose is to administer naloxone in order to reverse the effects of overdose. A recently published study showed that also providing buprenorphine immediately afterward reduced withdrawal discomfort and increased outpatient addiction follow-up care.
A separate article referenced data showing a nearly six-fold increase in patients accessing outpatient addiction treatment within 30 days of the overdose event.
These are highly encouraging finds which demonstrate the far-reaching effectiveness of medication-assistance in the treatment of opioid addiction. Saving a life through overdose reversal is obviously a critical benefit, but increasing motivation for follow-up treatment is a huge step in helping addicted individuals plug into a long-term solution.
Structured treatment which utilizes medication-assistance provides so much to those aspiring to face their addiction challenges. Naloxone, buprenorphine, and methadone have saved countless lives, and these medications have provided an unrivaled opportunity for those in opioid addiction to plot a new path in life.
The U.S. Dept. of Health and Human Services has awarded $1.5 billion in an effort to support States in their fight against opioid addiction.
The grant programs will provide funding to increase access to “24/7 Opioid Treatment Programs”. $104 million will be specifically allocated to bring treatment services to rural areas of the country that have been historically underserved.
While stabilizing and rebuilding lives through medication-assisted treatment is a priority, the prevention of overdose deaths is a distinct goal of the new funding initiative. Major confiscation of fentanyl continues month to month as law enforcement authorities intercept huge quantities of the drug pouring across the southern border.
Another $20.5 million is being earmarked for the development of programs that help connect individuals with addiction issues to local community resources that can enhance their overall recovery effort.
Additional focus will be placed on increasing the availability of naloxone which is the emergency medication that can quickly reverse the effects of opioid overdose. Thousands of lives have been saved in the last 10 years through the timely administration of naloxone to those who have overdosed.
The White House report outlines further efforts to disrupt global drug trafficking through the addition of more law enforcement officers.
Providence, Rhode Island is the first location in the United States to offer a mobile methadone service. This article profiles CODAC Behavioral Health who operate a 27 foot RV that has been modified to function as a mobile methadone unit.
The concept behind this innovative approach is to bring essential medication-assisted treatment services to the rural areas of Rhode Island where many prospective patients are underserved.
Access to methadone and buprenorphine-based treatments remains an ongoing challenge as nearly 83% of those with opioid use disorder (OUD) are not yet utilizing medication to help with their opioid withdrawal symptoms. Opioid withdrawal sickness is the primary driver of illicit opioid use, opioid overdose, and lifestyle disruption.
CODAC received their FDA approval in July 2022 to begin dispensing methadone from their mobile unit.
Methadone clinics are a lifesaver for many thousands of recovering individuals across the country. There are a number of new clinics opening each week, but the provision of a methadone mobile service offers an interesting alternative that will be closely watched and evaluated in the years ahead.
BrightView provides high quality addiction treatment with a specialty in opioid addiction recovery. Currently, the organization operates in six states: Ohio, Kentucky, Virginia, Delaware, North Carolina, and Massachusetts.
BrightView was originally founded by a doctor, a lawyer, and a businessman with the intent of transforming addiction medicine. In Cincinnati, opioid addiction had severely impacted the local community as it had done in so many other areas of the country.
Consequently, BrightView founders wanted to design a system of service delivery that would make it easy for people affected by opioid addiction to get the help they needed with minimal obstacles and delays.
While most BrightView clinics specialize in the use of buprenorphine, suboxone, and vivitrol, several clinics also offer methadone. Their recovery model is built upon a combination of top tier medication-assisted treatment in conjunction with counseling and behavioral therapies.
In addition to opioid-specific treatment services, BrightView also offers specialized treatment for alcohol, methamphetamine, and other substance use disorders. Being patient-centered is a hallmark of the company’s approach to helping.
Most BrightView facilities can see a patient within 24 hours of calling for an appointment. If interested in contacting BrightView, you can reach them at 866-928-5995.